Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Accident and Disability | 2,524.0 | 2,614.0 | 2,665.0 | 2,611.0 | 2,537.0 | 2,469.0 | 2,391.0 | 2,303.0 |
| Other Health | 1,542.0 | 1,571.0 | 1,548.0 | 1,508.0 | 1,445.0 | 1,415.0 | 1,395.0 | 1,371.0 |
| Cancer | 1,216.0 | 1,275.0 | 1,309.0 | 1,311.0 | 1,308.0 | 1,299.0 | 1,293.0 | 1,279.0 |
| Other | 1,207.0 | 1,105.0 | 1,028.0 | 1,013.0 | 999.0 | 984.0 | 954.0 | 906.0 |
| Aflac U.S. revenues | 6,489.0 | 6,565.0 | 6,550.0 | 6,443.0 | 6,289.0 | 6,167.0 | 6,033.0 | 5,859.0 |
| Revenue growth [+] | -1.2% | 0.2% | 1.7% | 2.4% | 2.0% | 2.2% | 3.0% | 1.2% |
| Accident and Disability | -3.4% | -1.9% | 2.1% | 2.9% | 2.8% | 3.3% | 3.8% | 0.8% |
| Other Health | -1.8% | 1.5% | 2.7% | 4.4% | 2.1% | 1.4% | 1.8% | 2.8% |
| Cancer | -4.6% | -2.6% | -0.2% | 0.2% | 0.7% | 0.5% | 1.1% | -0.3% |
| Marketing | | | | | 110.0 | 124.0 | 129.0 | 126.0 |
| EBIT | 1,478.0 | 1,268.0 | 1,272.0 | 1,285.0 | 1,245.0 | 1,208.0 | 1,101.0 | 1,073.0 |
| EBIT margin | 22.8% | 19.3% | 19.4% | 19.9% | 19.8% | 19.6% | 18.2% | 18.3% |
| |
| Total assets | 23,106.0 | 22,864.0 | 20,945.0 | 19,100.0 | 19,893.0 | 19,453.0 | 18,537.0 | 18,383.0 |
| ROA | 5.2% | 6.4% | 4.5% | 4.9% | 7.2% | 4.1% | 3.9% | 3.8% |
| |
| Revenue Mix | 29.4% | 29.6% | 29.4% | 29.6% | 29.0% | 27.3% | 28.9% | 25.8% |
| EBIT Mix | 26.6% | 28.8% | 27.2% | 30.6% | 29.2% | 27.9% | 26.5% | 22.3% |
|